InvestorsHub Logo
Followers 0
Posts 1588
Boards Moderated 0
Alias Born 07/27/2016

Re: None

Tuesday, 05/19/2020 12:21:18 PM

Tuesday, May 19, 2020 12:21:18 PM

Post# of 18805
I think people on this board need to consider the following:

Pro's

Aytu has a significant amount of money for a company with a little over $8kk in revs (currently)

They are in a good position to capitalize on the COVID market.

They are also looking a new products to sell.

They currently have a descent number of products to market.

Con's

Aytu's test kits for Covid 19 are not approved:

This is from a publication- Two U.S. companies — Premier Biotech of Minneapolis and Aytu Bioscience of Colorado — have been distributing the tests from unapproved Chinese manufacturers, according to health officials, FDA filings and a spokesman for one of the Chinese manufacturers. Many of the unapproved tests appear to have been shipped to the U.S. after the FDA relaxed its guidelines for tests in mid-March and before the Chinese government banned their export just over two weeks later.

Source: https://www.nbcnews.com/health/health-news/unapproved-chinese-coronavirus-antibody-tests-being-used-least-2-states-n1185131

Currently have a large number of shares outstanding. Easier to short and harder to move up. However, should make their loss/share lower in the next report.

The UV light they are looking at will take some time to work it's way through the FDA approval. Will most likely have to wait for someone else to get the approval and then try to sign a marketing agreement. Maybe they should also be looking at the red light therapy (633-810 nm). Red light is not destructive like UV.

The products they obtained through the acquisition of INNV are very expensive to bring to market. It takes about $1.30- $1.50 to get $1.00 in revs.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AYTU News